Next, the role of MC4R in the regulation of body weight has generated the interest of pharmaceutical companies that have created potent small-molecule agonists of MC4R to treat obesity and can be used to activate an MC4R-based RASSL. This evidence concerns the gene MC4R and obesity due to melanocortin 4 receptor deficiency.